Search

Christopher J. Novosad

Examiner (ID: 10390, Phone: (571)272-6993 , Office: P/3671 )

Most Active Art Unit
3671
Art Unit(s)
3671, 3616, 3501, 3641, 2899
Total Applications
3135
Issued Applications
2776
Pending Applications
115
Abandoned Applications
263

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 326636 [patent_doc_number] => 07514407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Spheron component peptides and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/444070 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16957 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514407.pdf [firstpage_image] =>[orig_patent_app_number] => 10444070 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444070
Spheron component peptides and pharmaceutical compositions May 22, 2003 Issued
Array ( [id] => 7426798 [patent_doc_number] => 20040229837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Treatment of neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 10/440345 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6557 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229837.pdf [firstpage_image] =>[orig_patent_app_number] => 10440345 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/440345
Treatment of neurodegenerative diseases May 14, 2003 Abandoned
Array ( [id] => 7341684 [patent_doc_number] => 20040191291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Composition and method for nerve regeneration' [patent_app_type] => new [patent_app_number] => 10/427741 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 100888 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191291.pdf [firstpage_image] =>[orig_patent_app_number] => 10427741 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/427741
Composition and method for nerve regeneration Apr 29, 2003 Abandoned
Array ( [id] => 6663664 [patent_doc_number] => 20030202990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Intracranial botulinum toxin therapy for focal epilepsy' [patent_app_type] => new [patent_app_number] => 10/421504 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27269 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20030202990.pdf [firstpage_image] =>[orig_patent_app_number] => 10421504 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/421504
Intracranial botulinum toxin therapy for focal epilepsy Apr 21, 2003 Issued
Array ( [id] => 232623 [patent_doc_number] => 07598048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Screening methods for identifying agents that modulate output of a circadian pacemaker' [patent_app_type] => utility [patent_app_number] => 10/417426 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26754 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598048.pdf [firstpage_image] =>[orig_patent_app_number] => 10417426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/417426
Screening methods for identifying agents that modulate output of a circadian pacemaker Apr 14, 2003 Issued
Array ( [id] => 5738068 [patent_doc_number] => 20060008458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Prevention of brain inflammation as a result of induced autoimmune response' [patent_app_type] => utility [patent_app_number] => 10/510820 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1909 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008458.pdf [firstpage_image] =>[orig_patent_app_number] => 10510820 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510820
Prevention of brain inflammation as a result of induced autoimmune response Apr 13, 2003 Abandoned
Array ( [id] => 5738068 [patent_doc_number] => 20060008458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Prevention of brain inflammation as a result of induced autoimmune response' [patent_app_type] => utility [patent_app_number] => 10/510820 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1909 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008458.pdf [firstpage_image] =>[orig_patent_app_number] => 10510820 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510820
Prevention of brain inflammation as a result of induced autoimmune response Apr 13, 2003 Abandoned
Array ( [id] => 7445552 [patent_doc_number] => 20040009593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury' [patent_app_type] => new [patent_app_number] => 10/406817 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14475 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009593.pdf [firstpage_image] =>[orig_patent_app_number] => 10406817 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/406817
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury Apr 3, 2003 Issued
Array ( [id] => 7201985 [patent_doc_number] => 20040086881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof' [patent_app_type] => new [patent_app_number] => 10/334360 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 65573 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086881.pdf [firstpage_image] =>[orig_patent_app_number] => 10334360 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/334360
Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof Mar 11, 2003 Abandoned
Array ( [id] => 6797016 [patent_doc_number] => 20030175890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'FAIL molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 10/384850 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 48514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175890.pdf [firstpage_image] =>[orig_patent_app_number] => 10384850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/384850
FAIL molecules and uses thereof Mar 9, 2003 Issued
Array ( [id] => 7436122 [patent_doc_number] => 20040002460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Spheron components useful in determining compounds capable of treating symptoms of Alzheimer\'s disease, and treatments and animal models produced therefrom' [patent_app_type] => new [patent_app_number] => 10/378065 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16286 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002460.pdf [firstpage_image] =>[orig_patent_app_number] => 10378065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/378065
Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom Mar 3, 2003 Abandoned
Array ( [id] => 7354845 [patent_doc_number] => 20040048795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors' [patent_app_type] => new [patent_app_number] => 10/375696 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11395 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048795.pdf [firstpage_image] =>[orig_patent_app_number] => 10375696 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/375696
Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors Feb 25, 2003 Abandoned
Array ( [id] => 5609325 [patent_doc_number] => 20060270841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Assays to monitor amyloid precursor protein processing' [patent_app_type] => utility [patent_app_number] => 10/504446 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 19930 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270841.pdf [firstpage_image] =>[orig_patent_app_number] => 10504446 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/504446
Assays to monitor amyloid precursor protein processing Feb 24, 2003 Abandoned
Array ( [id] => 4859115 [patent_doc_number] => 20080267965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Use of Bcma as an Immunoregulatory Agent' [patent_app_type] => utility [patent_app_number] => 10/505376 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11590 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267965.pdf [firstpage_image] =>[orig_patent_app_number] => 10505376 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505376
Use of Bcma as an Immunoregulatory Agent Feb 20, 2003 Abandoned
Array ( [id] => 6912320 [patent_doc_number] => 20050176078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Detection and/or monitoring of synuclein-related diseases' [patent_app_type] => utility [patent_app_number] => 10/503416 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7987 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176078.pdf [firstpage_image] =>[orig_patent_app_number] => 10503416 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503416
Detection and/or monitoring of synuclein-related diseases Feb 13, 2003 Abandoned
Array ( [id] => 6822119 [patent_doc_number] => 20030220280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration' [patent_app_type] => new [patent_app_number] => 10/359554 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5677 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220280.pdf [firstpage_image] =>[orig_patent_app_number] => 10359554 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/359554
Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration Feb 6, 2003 Abandoned
Array ( [id] => 7330648 [patent_doc_number] => 20040254348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel polypeptide and dna thereof' [patent_app_type] => new [patent_app_number] => 10/332738 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25937 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254348.pdf [firstpage_image] =>[orig_patent_app_number] => 10332738 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332738
Novel polypeptide and dna thereof Jan 9, 2003 Abandoned
Array ( [id] => 6797468 [patent_doc_number] => 20030176342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Novel potassium channel' [patent_app_type] => new [patent_app_number] => 10/332175 [patent_app_country] => US [patent_app_date] => 2003-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11232 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176342.pdf [firstpage_image] =>[orig_patent_app_number] => 10332175 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332175
Novel potassium channel Jan 6, 2003 Abandoned
Array ( [id] => 6683283 [patent_doc_number] => 20030119147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Novel SLGP protein and nucleic acid molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 10/336489 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40801 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119147.pdf [firstpage_image] =>[orig_patent_app_number] => 10336489 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/336489
Novel SLGP protein and nucleic acid molecules and uses therefor Jan 1, 2003 Abandoned
Array ( [id] => 4570524 [patent_doc_number] => 07824670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Use of il6r/il6 chimera in nerve cell regeneration' [patent_app_type] => utility [patent_app_number] => 10/498899 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11468 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824670.pdf [firstpage_image] =>[orig_patent_app_number] => 10498899 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498899
Use of il6r/il6 chimera in nerve cell regeneration Dec 30, 2002 Issued
Menu